AQR Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.8M Sell
1,016,429
-141,930
-12% -$10M 0.03% 649
2025
Q4
$78M Buy
1,158,359
+189,848
+20% +$12.8M 0.04% 541
2025
Q3
$71M Buy
968,511
+589,711
+156% +$39.2M 0.05% 509
2025
Q2
$19.7M Buy
378,800
+345,662
+1,043% +$19.7M 0.02% 803
2025
Q1
$2.11M Sell
33,138
-19,819
-37% -$1.15M ﹤0.01% 1576
2024
Q4
$2.53M Buy
52,957
+432
+0.8% +$22.2K ﹤0.01% 1400
2024
Q3
$3.01M Buy
52,525
+4,752
+10% +$272K ﹤0.01% 1294
2024
Q2
$2.5M Buy
47,773
+2,265
+5% +$99.3K ﹤0.01% 1356
2024
Q1
$1.85M Buy
45,508
+502
+1% +$18.8K ﹤0.01% 1451
2023
Q4
$1.66M Sell
45,006
-5,257
-10% -$198K ﹤0.01% 1425
2023
Q3
$1.92M Sell
50,263
-6,655
-12% -$273K ﹤0.01% 1343
2023
Q2
$2.05M Sell
56,918
-5,406
-9% -$184K ﹤0.01% 1252
2023
Q1
$2.38M Sell
62,324
-1,444
-2% -$67.7K 0.01% 1179
2022
Q4
$3.63M Buy
63,768
+5,431
+9% +$278K 0.01% 1026
2022
Q3
$2.31M Buy
58,337
+4,137
+8% +$183K 0.01% 1143
2022
Q2
$2.38M Sell
54,200
-3,288
-6% -$142K 0.01% 1030
2022
Q1
$2.29M Sell
57,488
-1,906
-3% -$67.9K ﹤0.01% 1106
2021
Q4
$2.39M Sell
59,394
-4,454
-7% -$166K ﹤0.01% 1072
2021
Q3
$2.6M Sell
63,848
-7,404
-10% -$310K ﹤0.01% 1014
2021
Q2
$3.24M Sell
71,252
-2,581
-3% -$114K 0.01% 981
2021
Q1
$3.08M Sell
73,833
-1,581
-2% -$72.2K 0.01% 970
2020
Q4
$3.22M Sell
75,414
-16,542
-18% -$595K 0.01% 941
2020
Q3
$2.42M Sell
91,956
-12,246
-12% -$341K ﹤0.01% 1022
2020
Q2
$2.79M Buy
104,202
+19,836
+24% +$447K ﹤0.01% 1015
2020
Q1
$1.52M Sell
84,366
-33,804
-29% -$642K ﹤0.01% 1178
2019
Q4
$2.1M Sell
118,170
-18,409
-13% -$319K ﹤0.01% 1253
2019
Q3
$2.12M Sell
136,579
-147
-0.1% -$2.42K ﹤0.01% 1260
2019
Q2
$2.35M Sell
136,726
-617
-0.4% -$9.96K ﹤0.01% 1209
2019
Q1
$2.21M Buy
137,343
+958
+0.7% +$15.5K ﹤0.01% 1283
2018
Q4
$2M Sell
136,385
-35,388
-21% -$565K ﹤0.01% 1248
2018
Q3
$3.12M Hold
171,773
﹤0.01% 1194
2018
Q2
$2.9M Hold
171,773
﹤0.01% 1260
2018
Q1
$3.37M Buy
171,773
+8,948
+5% +$173K ﹤0.01% 1148
2017
Q4
$3.3M Buy
162,825
+48,577
+43% +$893K ﹤0.01% 1180
2017
Q3
$1.99M Buy
114,248
+90,500
+381% +$1.23M ﹤0.01% 1382
2017
Q2
$304K Buy
23,748
+8,202
+53% +$110K ﹤0.01% 2031
2017
Q1
$202K Hold
15,546
﹤0.01% 2112
2016
Q4
$153K Sell
15,546
-83
-0.5% -$909 ﹤0.01% 2181
2016
Q3
$188K Hold
15,629
﹤0.01% 2170
2016
Q2
$135K Sell
15,629
-10,282
-40% -$101K ﹤0.01% 2147
2016
Q1
$245K Sell
25,911
-61,148
-70% -$575K ﹤0.01% 2063
2015
Q4
$1.51M Sell
87,059
-9,171
-10% -$146K ﹤0.01% 1385
2015
Q3
$1.29M Sell
96,230
-9,212
-9% -$185K ﹤0.01% 1312
2015
Q2
$2.38M Buy
105,442
+71,842
+214% +$1.26M ﹤0.01% 1109
2015
Q1
$479K Buy
33,600
+13,200
+65% +$190K ﹤0.01% 1713
2014
Q4
$197K Sell
20,400
-28,155
-58% -$250K ﹤0.01% 2365
2014
Q3
$442K Sell
48,555
-16,400
-25% -$156K ﹤0.01% 1992
2014
Q2
$642K Sell
64,955
-47,800
-42% -$406K ﹤0.01% 1876
2014
Q1
$1.43M Buy
112,755
+12,300
+12% +$183K ﹤0.01% 1501
2013
Q4
$1.51M Buy
100,455
+80,055
+392% +$1.03M ﹤0.01% 1520
2013
Q3
$225K Hold
20,400
﹤0.01% 2300
2013
Q2
$162K Buy
+20,400
New +$130K ﹤0.01% 2242

Other funds holding HALO

AQR Capital Management's HALO Position: Q1 2026 in Review

AQR Capital Management reduced its Halozyme (HALO) stake by 12% in Q1 2026, selling an estimated $10M and leaving 1,016,429 shares worth $64.8M. The position accounts for 0.03% of the portfolio, ranked #649.

AQR Capital Management first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $78M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • AQR Capital Management held 1,016,429 shares of Halozyme worth $64.8M as of Q1 2026.
  • AQR Capital Management sold 141,930 Halozyme shares in Q1 2026, an estimated $10M.
  • Halozyme made up 0.03% of AQR Capital Management's portfolio in Q1 2026, its #649 holding.
  • AQR Capital Management first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • AQR Capital Management's Halozyme position peaked at $78M in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.